The following schedule summarizes the non-cash investing and financing activities of the Company for the six months ended June 30, 2026 and 2025 (in thousands):


	Six Months Ended June 30,
	2026			2025
Proceeds deposited in escrow through sale of real estate interests	$	7,992		$	48,699
Capital expenditures accrual	$	52,225		$	45,193
Conversion of other financing receivable to cost method investment	$	2,423		$	-
Lease liabilities arising from obtaining operating right-of-use assets	$	1,424		$	7,377
Decrease in noncontrolling interests’ carrying amount, net (including redeemable)	$	(3,221	)	$	(555	)
Surrender of restricted common stock/units	$	6,371		$	11,646
Declaration of dividends/distributions paid in succeeding period	$	6,364		$	6,364

The following table provides a reconciliation of cash, cash equivalents and restricted cash recorded on the Company’s Condensed Consolidated Balance Sheets to the Company’s Condensed Consolidated Statements of Cash Flows (in thousands):


	As of June 30, 2026		As of December 31, 2025
Cash and cash equivalents	$	699,242	$	211,648
Restricted cash		1,141		1,146
Total cash, cash equivalents and restricted cash	$	700,383	$	212,794